Aurinia Pharmaceuticals (AUPH) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Aurinia Pharmaceuticals is set to participate in the Jefferies London Healthcare Conference, engaging with investors through one-on-one meetings and a fireside chat. The company, known for its FDA-approved treatment for lupus nephritis, continues to advance its pipeline with promising therapies for autoimmune diseases.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.
